Abstract

This study aimed at estimating the healthcare costs and identifying potential drivers associated with metastatic castration-resistant prostate cancer (mCRPC).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Second-line treatment options in metastatic castration-resistant prostate cancer: A comparison of key trials with recently approved agents
Amit Bahl ... Johann De Bono
Evidence-based Oncology | VOL. 40
Amit Bahl, et. al.Amit Bahl ... Johann De Bono
16 Aug 2013
Novel quantitative software for automatically excluding red bone marrow on whole-body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study.
Yuki Kohada ... Jun Ito
International journal of urology : official journal of the Japanese Urological Association | VOL. 30
Yuki Kohada, et. al.Yuki Kohada ... Jun Ito
20 Dec 2022
Cancer treatment: at what cost?
Beverley Anderson
Nursing and Residential Care | VOL. 17
Beverley AndersonBeverley Anderson
02 Mar 2015
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer.
Manish Kohli ... Heidi Fettke
eBioMedicine | VOL. 54
Manish Kohli, et. al.Manish Kohli ... Heidi Fettke
01 Apr 2020
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
EQ-5D-5L population scores in mainland China: results from a nationally representative survey 2021
Qiang Yao ... Chaojie Liu
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Qiang Yao, et. al.Qiang Yao ... Chaojie Liu
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
View more papers